Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
36923287 | 0 | Bunch CM, Chang E, Moore EE, et al. SHock-INduced Endotheliopathy (SHINE): A mechanistic justification for viscoelastography-guided resuscitation of traumatic and non-traumatic shock. Front Physiol. 2023 Feb 27;14:1094845. doi: 10.3389/fphys.2023.1094845. eCollection 2023. | |
36759279 | 0 | Zheng Z, Mukhametova L, Boffa MB, et al. Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis. J Thromb Haemost. 2023 Jan 14:S1538-7836(23)00036-3. doi: 10.1016/j.jtha.2023.01.008. | |
36594041 | 0 | Fraser DD, Patel MA, Van Nynatten LR, et al. Cross-immunity against SARS-COV-2 variants of concern in naturally infected critically ill COVID-19 patients. Heliyon. 2023 Jan;9(1):e12704. doi: 10.1016/j.heliyon.2022.e12704. Epub 2022 Dec 29. | |
35150946 | 0 | Cook-Richardson S, Addo A, Kim P, et al. Show Me the Money, I'll Show You My Complications: Impacts of Incentivized Incident Self-Reporting Among Surgeons. J Surg Res. 2022 Feb 9;274:136-144. doi: 10.1016/j.jss.2021.12.012. | |
34739003 | 0 | Esposito EC, Kufera JA, Wolff TW, et al. Factors associated with stroke formation in blunt cerebrovascular injury: An EAST multicenter study. J Trauma Acute Care Surg. 2022 Feb 1;92(2):347-354. doi: 10.1097/TA.0000000000003455. | |
33826233 | 0 | Juneja GK, Castelo M, Yeh CH, et al. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study. J Thromb Haemost. 2021 Jun;19(6):1546-1557. doi: 10.1111/jth.15327. Epub 2021 May 1. | |
32881272 | 0 | Thachil J, Longstaff C, Favaloro EJ, et al. The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis. J Thromb Haemost. 2020 Sep;18(9):2408-2411. doi: 10.1111/jth.14956. | |
32506822 | 0 | Ni R, Neves MAD, Wu C, et al. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets. J Thromb Haemost. 2020 Sep;18(9):2364-2376. doi: 10.1111/jth.14950. | |
31881626 | 0 | Janhofer DE, Lakhiani C, Kim PJ, et al. The Utility of Preoperative Venous Testing for Lower Extremity Flap Planning in Patients with Lower Extremity Wounds. Plast Reconstr Surg. 2020 Jan;145(1):164e-171e. doi: 10.1097/PRS.0000000000006384. | |
31843251 | 0 | Kahn SR, Julian JA, Kearon C, et al. Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2020 Jan;8(1):8-23.e18. doi: 10.1016/j.jvsv.2019.03.023. | |
31489277 | 0 | Hashmi A, Kim P, Ahmad SW, et al. Superior Sagittal Venous Sinus Thrombosis in a Patient with Illicit Testosterone Use. Cureus. 2019 Aug 26;11(8):e5491. doi: 10.7759/cureus.5491. | |
31309685 | 0 | Medeiros SK, Zafar N, Liaw PC, et al. Purification of silica-free DNA and characterization of its role in coagulation. J Thromb Haemost. 2019 Nov;17(11):1860-1865. doi: 10.1111/jth.14565. Epub 2019 Jul 30. | |
31005064 | 0 | Shaya SA, Gani DM, Weitz JI, et al. Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi. Thromb Haemost. 2019 Jun;119(6):992-999. doi: 10.1055/s-0039-1685141. Epub 2019 Apr 20. | |
30985986 | 0 | Kim PY, Di Giuseppantonio LR, Wu C, et al. An assay to measure levels of factor Xa inhibitors in blood and plasma. J Thromb Haemost. 2019 Jul;17(7):1153-1159. doi: 10.1111/jth.14451. Epub 2019 May 10. | |
30537547 | 0 | Ravina K, Strickland BA, Buchanan IA, et al. Postoperative Antiplatelet Therapy in the Treatment of Complex Basilar Apex Aneurysms Implementing Hunterian Ligation and Extracranial-to-Intracranial Bypass: Review of the Literature with an Illustrative Case Report. World Neurosurg. 2019 Mar;123:113-122. doi: 10.1016/j.wneu.2018.11.237. Epub 2018 Dec 8. | |
29466159 | 0 | Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018 Feb 22;378(8):699-707. doi: 10.1056/NEJMoa1712746. | |
28640323 | 0 | Wu C, Stafford AR, Fredenburgh JC, et al. Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential. Thromb Haemost. 2017 Jul 26;117(8):1509-1517. doi: 10.1160/TH17-01-0054. Epub 2017 Jun 22. | |
28219843 | 0 | Pepler L, Wu C, Dwivedi DJ, et al. The impact of the endothelial protein C receptor on thrombin generation and clot lysis. Thromb Res. 2017 Apr;152:30-37. doi: 10.1016/j.thromres.2017.02.002. Epub 2017 Feb 3. | |
27694320 | 0 | Mitchell JL, Lionikiene AS, Georgiev G, et al. Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity. Blood. 2016 Dec 15;128(24):2834-2845. doi: 10.1182/blood-2015-10-673285. Epub 2016 Sep 30. | |
26494232 | 0 | Gould TJ, Vu TT, Stafford AR, et al. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis. Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2544-53. doi: 10.1161/ATVBAHA.115.306035. Epub 2015 Oct 22. | |
25883230 | 0 | Kim PY. Platelets: connecting clotting and lysis. Blood. 2015 Apr 16;125(16):2459. doi: 10.1182/blood-2015-03-632158. | |
25789495 | 0 | Henderson SJ, Stafford AR, Leslie BA, et al. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation. Thromb Haemost. 2015 Jun;113(6):1278-88. doi: 10.1160/TH14-09-0771. Epub 2015 Mar 19. |